Bumetanide
edema associated with congestive heart failure, hepatic disease, renal disease
Boxed warning
- WARNING Bumetanide is a potent diuretic which, if given in excessive amounts, can lead to a profound diuresis with water and electrolyte depletion. Therefore, careful medical supervision is required, and dose and dosage schedule have to be adjusted to the individual patient’s needs ( see DOSAGE AND ADMINIST RAT ION ).
Indications
- edema associated with congestive heart failure
- hepatic disease
- renal disease
Adult dosing
- initial oral: dose: 0.5; unit: mg; route: PO; interval: 0.5 mg to 2 mg once daily; fixed: true; labelExcerpt: The usual total daily dosage of bumetanide tablets are 0.5 mg to 2 mg and in most patients are given as a single dose. If the diuretic response to an initial dose of bumetanide tablets is not adequate, in view of its rapid onset and short duration of action, a second or third dose may be given at 4- to 5- hour intervals up to a maximum daily dose of 10 mg.
Pediatric dosing
- Consult pharmacy/current label
Renal adjustment
- Consult pharmacy/current label
Hepatic adjustment
- Keep dosage to a minimum.
Contraindications
- Anuria
- Hepatic coma
- Severe electrolyte depletion
- Hypersensitivity to bumetanide
Clinical pearls
- Potent diuretic; monitor for volume and electrolyte depletion.
- Patients allergic to sulfonamides may have cross-hypersensitivity.
- Potentially ototoxic; risk increases with rapid IV administration at high doses.
- Intermittent dosing (e.g., alternate days) is recommended for continued control of edema.
Source and review
- DailyMed label (bumetanide), Set ID 43844210-3850-4431-848d-bd168cb3f21e, effective 2026-10-09. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties